lidocaine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

lidocaine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elias, PM; Feingold, KR; Gao, WN; Guy, RH; Thornfeldt, CR; Tsai, JC1

Other Studies

1 other study(ies) available for lidocaine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Journal of pharmaceutical sciences, 1996, Volume: 85, Issue:6

    Topics: Acetone; Administration, Cutaneous; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Cholesterol Esters; Fatty Acids; Fatty Acids, Monounsaturated; Fluvastatin; Furans; Hypolipidemic Agents; Indoles; Lidocaine; Male; Mice; Mice, Hairless; Permeability; Skin; Skin Absorption

1996